Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards - Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an

ADVERTISEMENT

Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards
Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an avian flu pandemic


BioPharm International
Volume 19, Issue 2

8. Slater (2004), "Industry and Government Perspective in Influenza Control," Texas Heart Inst. J. 31:42-44.

9. Coyle (2005), "Consumer Groups Slam Vaccine Bill," National Law Journal Dec. 13, 2005.

10. Trivalent influenza vaccines were added to the VICP in July 2005, see http://www.hrsa.gov/osp/vicp/

11. See Coyle (2005), supra.

12. Section 6 of S. 1878, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here